Bharat Serums – Biopharmaceuticals and Women's Health
Bharat Serums
Bharat Serums and Vaccines Limited (BSV) is an Indian biopharmaceutical company founded in 1971, with its head office in Navi Mumbai, Maharashtra. In October 2024 it was fully acquired by India's Mankind Pharma and now operates as part of the Mankind group.
BSV focuses on women's health and reproductive medicine, including IVF treatments, as well as critical care and emergency medicine. Much of its portfolio is biological: recombinant FSH and hCG, menotropins, anti-thymocyte globulin, equine rabies immunoglobulin and monoclonal anti-Rh(D) antibodies.
The company is known for medicines in special dosage forms: amphotericin B as a lipid emulsion and liposomal amphotericin B for severe fungal infections, propofol emulsion, and ulinastatin — a trypsin inhibitor derived from human urine, used in critical care, including acute pancreatitis.
Manufacturing is based in Ambernath, Maharashtra, and research and development in Mumbai. Outside India, the company has offices in the Philippines, Malaysia and Germany.
Unifarm carries Bharat Serums medicines: Amphomul (amphotericin B) and U-Tryp (ulinastatin).